Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit
Sponsor: St. Louis University
Listed as NCT04210427, this PHASE4 trial focuses on Cystic Fibrosis Gastrointestinal Disease and remains completed. Sponsored by St. Louis University, it has been updated 13 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jul 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Feb 2023 — Jul 2023 [monthly]
Recruiting PHASE4
▶ Show 8 earlier versions
-
Jul 2022 — Feb 2023 [monthly]
Recruiting PHASE4
-
Sep 2021 — Jul 2022 [monthly]
Recruiting PHASE4
-
Mar 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE4
-
Jun 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Active Not Recruiting → Recruiting
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — May 2020 [monthly]
Recruiting PHASE4
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE4
First recorded
Dec 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- St. Louis University
For direct contact, visit the study record on ClinicalTrials.gov .